I assume there reference to commencing open label extension is in fact the Lavender study for 12 months. If so, then all the girls will be taking Trof, so it will soon become very obvious if the drug works. Acadia will be the first to know......so what cpuld that mean....?? Again, just my opinion, but exciting times.
Ann: 5 Orphan Drug programs and Rett in Phase 3 funded by partner, page-16
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.48 |
Change
-0.290(1.73%) |
Mkt cap ! $2.076B | |||
| Open | High | Low | Value | Volume |
| $16.58 | $16.74 | $16.40 | $9.107M | 549.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 864 | $16.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.50 | 1668 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |